Infasurf (Calfactant) aerosol for infants with bronchiolitis
This study enrolls infants who are admitted to Oishei Children's hospital's Pediatric Intensive Care Unit (PICU) with bronchiolitis. The purpose of this study is to see how a medication for the condition compares with usual care.
If your child participates in this study, they will be randomized (like the flip of a coin) to receive either the study medication (aerosolized Infasurf® surfactant) or usual care. If they are receiving the study medication, it will be given with a device that looks like a pacifier. Infants who get the study medication will get it for 1-2 hours with one repeat dose possible; the other group of participants will receive usual care at the direction of their attending physician. This study takes place in the pediatric intensive care unit (PICU) at Oishei Children’s Hospital.
The objective of this pilot study is to optimize the aerosol delivery technique and determine the feasibility and relative safety of aerosol surfactant therapy in the clinical setting
Children (infants) less than 8 months of age.
Admitted to PICU with bronchiolitis.
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the
contact information above or email email@example.com and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality
assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided
in the aforementioned ways, please contact firstname.lastname@example.org.